See also this year's filing and all EDGAR filings for this company.
PDF Report 0000891293_2023_CTI_BIOPHARMA_CORP.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000891293')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000891293, CTI BIOPHARMA CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 99,396,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 23,226,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 3,303,000 |
| 4 | LiabilitiesCurrent | 81,134,000 |
| 5 | LiabilitiesNoncurrent | 1,234,000 |
| 6 | remainder_Liabilities | 61,134,000 |
| 7 | CostOfGoodsAndServicesSold | 3,514,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 84,826,000 |
| 9 | ResearchAndDevelopmentExpense | 36,895,000 |
| 10 | remainder_Expenses | 8,510,000 |
| 11 | remainder_Revenues | 53,948,000 |
| 12 | remainder_NetIncome | -13,195,000 |
| 13 | remainder_ComprehensiveNetIncome | -35,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 125,925,000 |
| 1 | Liabilities | 143,502,000 |
| 2 | Expenses | 133,745,000 |
| 3 | Revenues | 53,948,000 |
| 4 | StockholdersEquity | -17,577,000 |
| 5 | NetIncome | -92,992,000 |
| 6 | ComprehensiveNetIncome | -93,009,500 |
| 7 | BaseVar | 235,175,000 |
| 8 | EconomicCapitalRatio | -0.915 |
Edgar->Model Mapping
Feature Distribution
Change over Time
